Conwanda completes a new round of financing

Kangwanda has a complete international team with experience in the whole process of innovative drug development. The professional fields of members cover medicinal chemistry, biology, pharmaceutical engineering, immunology, pharmacology and toxicology, clinical medicine, bioinformatics, and pharmaceutical regulations. , intellectual property, financial business and other links in the new drug creation industry chain. Recently, Conwanda completed a new round of financing and the introduction of strategic partners. This round is jointly participated by Dongheng Industrial Group, Huafang Capital and Blue Mountain Investment. The funds are mainly used for the clinical research of Conwanda’s new generation of oncolytic virus pipeline products and the development of follow-up guided virus products.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.